|
No device malfunction was reported.In response to reports of acute kidney injury associated with histotripsy, histosonics has incorporated the following warning into its labeling: "as reported in other liver-directed therapies, multiple or large-volume liver treatments have been associated with acute kidney injury (aki).When planning extensive or multiple treatments, evaluate and monitor the patient for signs of aki.".
|
|
On (b)(6) 2025, a 64-year-old female with a diagnosis of colorectal cancer metastatic to the liver underwent histotripsy treatment to five separate targets involving segments 2/3, 4a/b, and 7, for a total ptv of ~161 cm3.The procedure was completed without intraoperative complications.Post-procedure, both ultrasound and ct imaging revealed unremarkable findings with no evidence of procedural complications.However, the patient developed a transient acute kidney injury (aki), with serum creatinine rising from 47.9 mol/l pre-treatment to 444 mol/l by (b)(6), subsequently normalizing by (b)(6).The nephrology team attributed the aki to the histotripsy procedure.Concurrently, the patient developed hyponatremia, with serum sodium levels dropping from normal pre-treatment values to 118 mmol/l on (b)(6) and a nadir of 116 mmol/l on (b)(6), returning to normal by (b)(6).These abnormalities were managed supportively.The patient was also noted to have abdominal distension during recovery.An ultrasound confirmed the presence of ascites.Additionally, a contrast-enhanced mri was performed one day post-treatment for further evaluation.The patient received a short steroid (predinsolone) taper post-procedure consisting of 30 mg delivered on day 1, 20 mg on day 2, and 10 mg on day 3.Following hospitalization, the patient was discharged in stable condition.Follow-up communication indicated that the patient was recovering well, with full resolution of the acute kidney injury and other post-treatment complications.No device malfunctions or other noteworthy events occurred during the case.
|